GSK paves way for biopharmaceuticals growth

September 9, 2010
Research and Development GlaxoSmithKline, Lonza, biologics

GlaxoSmithKline has handed Swiss contract manufacturer Lonza a contract to produce clinical trial batches of five monoclonal antibodies that are …

Universities attack European research grant

September 9, 2010
Research and Development EFPIA, IMI, Innovative Medicines Initiative, academia

A European initiative aimed at fostering new medical research is neglecting its public partners in favour of its private ones, …

EU set to pass stricter laws for experiments on animals

September 9, 2010
Research and Development Animal testing, Animal tests

The number of animals used in scientific experiments will be reduced under new EU legislation agreed by the European Parliament …

Tzvi Palash joins Protalix BioTherapeutics

September 9, 2010
Manufacturing and Production, Research and Development Portalix BioTherapeutics, appointment, manufacturing and production, research and development

Protalix BioTherapeutics has appointed Tzvi Palash to the newly-created position of chief operating officer. He will be responsible for overseeing …

J&J and Merck heading for showdown over drug rights

September 8, 2010
Sales and Marketing Johnson & Johnson, Merck, Remicade

Johnson & Johnson’s disagreement with Merck over rights to two arthritis drugs is set to come to a head in …

inVentiv Health acquires French advertising group

September 8, 2010
Medical Communications France, advertising, inVentiv Health

InVentiv Health is to acquire Star Terre Santé, a leading group of healthcare marketing and communications agencies based in Paris. …

Pharma sector optimism growing

September 8, 2010
Sales and Marketing Eversheds, economic climate

Pharma execs are more confident about the sector’s outlook than they were at the start of the year. A survey …

Greece to cut 4,000 drug prices by a fifth

September 8, 2010
Sales and Marketing Greece, economic climate, price cuts, pricing & Reimbursement

The Greek government has released a list of over 4,000 drugs on which it will impose heavy price cuts. This …

Andreotti

BMS to acquire ZymoGenetics

September 8, 2010
Research and Development, Sales and Marketing BMS, hepatitis

 Bristol-Myers Squibb is to acquire biopharma company ZymoGenetics for $885 million to add to its ‘string of pearls’of small biotech …

GSK patient recruitment head joins Exco InTouch

September 8, 2010
Research and Development Exco InTouch, appointment, research and development

Judith Teall has been appointed director of patient recruitment at clinical trial technology company Exco InTouch. She has spent more …

Dr Meena Jain

Working Life: Dr Meena Jain

September 8, 2010
Business Services, Research and Development Napp, Working Life, careers, recruitment

How did you find your way into your most current role? I’ve been at Napp for four years now having …

PCT managers have ‘no automatic right’ to GP commissioning

September 8, 2010
GP, NHS, commissioning, government

Primary care trust managers should not have a legal right to transfer to similar roles in GP commissioning groups, according …

Pfizer drops brain cancer vaccine

September 7, 2010
Research and Development Celldex Therapeutics, Pfizer, cancer vaccine

Pfizer has dropped its experimental brain cancer vaccine rindopepimut, handing back worldwide rights to Celldex Therapeutics from November. Rindopepimut targets …

Roche signs Alzheimer’s deal with reMYND

September 7, 2010
Research and Development Alzheimer's, Parkinson's, Roche, reMYND

Roche has signed a deal with Belgian biotech reMYND to develop new treatments for patients with Alzheimer’s and Parkinson’s disease. …

Merck averts day in court over Dutch plant closure

September 7, 2010
Manufacturing and Production, Research and Development Merck & Co, Netherlands, job cuts

Merck & Co has postponed the planned closure of the former Organon facility in Oss, the Netherlands, after weeks of …

FDA cites another Sun Pharma unit for GMP violations

September 7, 2010
Manufacturing and Production Sun Pharma, manufacturing compliance

Sun Pharmaceuticals’ manufacturing operations have been found wanting by FDA for the second time in recent months, once again for …

Pharma manufacturing news in brief

September 7, 2010
Manufacturing and Production Aegis Protek, Alexion, Halozyme, Ranbaxy, SemBioSys

A round-up of pharma manufacturing developments from Ranbaxy, SemBioSys, Halozyme, Aegis Protek, Alexion and Thomson/Rondaxe. Ranbaxy Laboratories of India has …

Stephen Stamp joins board at Eusa Pharma

September 7, 2010
Sales and Marketing Eusa Pharma, appointment, sales and marketing

Transatlantic specialty company Eusa Pharma has appointed Stephen Stamp to its board as an independent non-executive director. Stephen has previously …

Russian API manufacturer eyes IPO and acquisitions

September 7, 2010
Manufacturing and Production API, Pharmsynthez, Russia

Russian active pharmaceutical ingredient manufacturer Pharmsynthez is planning a listing on the MICEX stock exchange to help it expand beyond …

New form of Levitra wins EU approval

September 7, 2010
Sales and Marketing Bayer, Levitra, erectile dysfunction

Bayer is to launch a new formulation of its erectile dysfunction drug Levitra. The European Commission granted Levitra (verdenafil HCI) …

The Gateway to Local Adoption Series

Latest content